-
1 Comment
Tianjin Tianyao Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 8.5% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Tianjin Tianyao Pharmaceuticals Co., Ltd's total revenue rose by 5.4% to $749M since the same quarter in the previous year.
Its net income has dropped by 32.0% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 169.3% to $53M since the same quarter in the previous year.
Based on the above factors, Tianjin Tianyao Pharmaceuticals Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE000001840 |
| Market Cap | 4B |
|---|---|
| Beta | 0.41 |
| PE Ratio | 32.5 |
| Target Price | 5.6 |
| Dividend Yield | None |
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1939 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600488.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
